Viking Therapeutics, Inc. IPO Research Information

Viking Therapeutics, Inc. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Viking Therapeutics, Inc., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Viking Therapeutics, Inc.	VKTX - NASDAQ	$10.00-$12.00	$8.00	$8.50	3 million	4/29/2015
Underwriter(s): Laidlaw & Company (UK) Ltd.
Co-Manager(s): Feltl and Company,Inc.
Industry: Health Care
Filing(s): Filed 2014-07-02 Terms Added 2014-09-02 Amended Prospectus 2015-03-02 Amended Prospectus 2015-04-10

Viking Therapeutics, Inc. Quote & Chart - Click for current quote - VKTX

About Viking Therapeutics, Inc. (adapted from Viking Therapeutics, Inc. prospectus):
They are a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class or best-in-class therapies for metabolic and endocrine disorders.

This description is adapted from VikingTherapeuticsInc-VKTX prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as VikingTherapeuticsInc-VKTX "VKTX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.